Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...

Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under ...

DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.

Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.

Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling ...

A Drug Enforcement Administration (DEA) judge has ordered the agency to respond to new allegations that it opposes the Biden ...

Attorneys for a cannabis company and advocacy group that are set to testify in the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearing process beginning this month say new evidence ...

The DEA rejected a September request from Colorado officials to participate in the United States' historic marijuana ...

The latest announcement is out from Village Farms International ( (VFF) ).

Recreational cannabis is now legal in 24 states and three more could legalize some form of marijuana sales this year. But ...

Despite legalization disappointments from 2024, the cannabis industry is far from standing still as the calendar changes over ...

As we rev up in 2025, here’s what I see as the main issues/events to watch (and maybe act on) in the industry: For years, “cannabis litigation” didn’t exist because business was conducted in the ...